Soares Karen
Chief Legal Officer
- Shares
- 19,275
- Price
- $4.66
- Value
- $89,822
CLOV
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$1,645,000
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$3,942,269
6 distinct insiders
Highlighted alerts
8
22 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CLOV overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 15, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on October 15, 2024. The restricted stock units vest quarterly, with a final vesting on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
Soares Karen
Chief Legal Officer
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Wai Conrad
CEO, Counterpart Health
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
Soares Karen
Chief Legal Officer
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Wai Conrad
CEO, Counterpart Health
Edwards Carladenise Armbrister
Director
Priest Brady Patrick
CEO of Clover Care Services
Reynoso Jamie L.
CEO, Medicare Advantage
Priest Brady Patrick
CEO of Home Care
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L.
CEO, Medicare Advantage
Loengard Anna U
Director
Loengard Anna U
Director
Garipalli Vivek
Director
Garipalli Vivek
Director
Reynoso Jamie L.
CEO, Medicare Advantage
Wai Conrad
CEO, Counterpart Health
Wai Conrad
CEO, Counterpart Health
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Soares Karen Chief Legal Officer | Sale | 19,275 | $4.66 | $89,822 | |
| Oct 19, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 4,066 | $4.41 | $17,931 | |
| Oct 07, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 2,006 | $4.63 | $9,288 | |
| Sep 17, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 1,921 | $4.56 | $8,760 | |
| Sep 15, 2026 | Wai Conrad CEO, Counterpart Health | Sale | 300,000 | $4.72 | $1,416,000 | |
| Sep 14, 2026 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | Sale | 20,000 | $5.16 | $103,200 | |
| Jul 20, 2026 | Soares Karen Chief Legal Officer | Sale | 51,700 | $4.51 | $233,167 | |
| Jul 17, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 4,839 | $4.53 | $21,921 | |
| Jul 08, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 2,384 | $4.68 | $11,157 | |
| Jun 17, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 2,360 | $4.78 | $11,281 | |
| Jun 11, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 7,289 | $4.91 | $35,789 | |
| May 28, 2026 | Wai Conrad CEO, Counterpart Health | Sale | 220,426 | $3.99 | $879,500 | |
| May 18, 2026 | Edwards Carladenise Armbrister Director | Sale | 67,160 | $3.42 | $229,687 | |
| May 13, 2026 | Priest Brady Patrick CEO of Clover Care Services | Sale | 98,039 | $3.52 | $345,097 | |
| Mar 18, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 5,833 | $1.91 | $11,141 | |
| Mar 04, 2026 | Priest Brady Patrick CEO of Home Care | Sale | 175,000 | $2.17 | $379,750 | |
| Jan 20, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 4,597 | $2.58 | $11,860 | |
| Jan 07, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 2,102 | $2.53 | $5,318 | |
| Dec 18, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 4,913 | $2.61 | $12,823 | |
| Nov 04, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 30,385 | $3.58 | $108,778 | |
| Oct 17, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 16,514 | $2.69 | $44,423 | |
| Oct 07, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 2,012 | $2.65 | $5,332 | |
| Sep 17, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 4,914 | $3.09 | $15,184 | |
| Aug 13, 2025 | Loengard Anna U Director | Purchase | 14,500 | $2.59 | $37,555 | |
| Aug 13, 2025 | Loengard Anna U Director | Purchase | 12,000 | $2.60 | $31,200 | |
| Aug 08, 2025 | Garipalli Vivek Director | Purchase | 31,980 | $2.17 | $69,397 | |
| Aug 07, 2025 | Garipalli Vivek Director | Purchase | 415,000 | $2.24 | $929,600 | |
| Aug 04, 2025 | Reynoso Jamie L. CEO, Medicare Advantage | Sale | 6,823 | $2.89 | $19,718 | |
| Jul 23, 2025 | Wai Conrad CEO, Counterpart Health | Sale | 91,197 | $3.32 | $302,774 | |
| Jul 22, 2025 | Wai Conrad CEO, Counterpart Health | Sale | 118,600 | $3.29 | $390,194 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.